Knocking the 'sox' off cancer and lymphatic disorders

October 19, 2008

Researchers have identified a gene critical for the development of the lymphatic system in a discovery that will have implications for treatment of cancer and lymphatic disorders and other diseases.

The team, led by Professor Peter Koopman and Dr Mathias François from the Institute for Molecular Bioscience at The University of Queensland (UQ), found that a single gene - Sox18 - triggers the development of the lymphatic vessels.

"The rate at which new lymphatic vessels can form is thought to be one of the key factors in determining how quickly a tumour can spread and thus how severely a patient will be affected by cancer," Professor Koopman said.

"The lymphatic vessels also play a central role in maintaining fluid balance in the body and carrying infection-fighting white blood cells, so greater knowledge about the lymphatic system can offer insights and suggest therapies for a range of diseases."

The team made the discovery, reported today (Monday, October 20) in leading science journal Nature, by examining mice in which Sox18 had been inactivated. They found that the development of lymphatic vessels was massively disrupted.

"We suspected Sox18 might play a critical role in lymphatic vessel formation after observing that mice with one inactivated copy of the gene displayed similar symptoms to humans with a genetic condition that affects the lymphatic system, known as HLT," Professor Koopman said.

"It turns out that Sox18 has a much more important role than we first thought - in fact, it's the master controller of lymphatic vessel development."

The team will now focus on finding genes regulated by Sox18 and determining how this regulation occurs, which may suggest ways of promoting or preventing lymphatic vessel formation.

"If we know how to prevent lymphatic vessels from forming, then we will be a lot closer to halting the spread of tumours through the body. Conversely, if we know how to stimulate the formation of these vessels, then it might be possible to treat diseases such as lymphedema," Professor Koopman said.

Lymphedema occurs when the lymphatic vasculature is impaired, causing a build-up of fluid in part of the body, which leads to painful and dangerous swelling of that body part, and, if left untreated, deformity.

The discovery was the result of three years of research by an international team of scientists from Australia, Italy and Hong Kong, led by UQ and supported by a number of organisations including the Australian Cancer Research Foundation, the National Health and Medical Research Council of Australia, the Heart Foundation of Australia, and the Australian Research Council.
-end-


Research Australia

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.